BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 27240341)

  • 1. Heterogeneous Pathology of Melasma and Its Clinical Implications.
    Kwon SH; Hwang YJ; Lee SK; Park KC
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane.
    Torres-Álvarez B; Mesa-Garza IG; Castanedo-Cázares JP; Fuentes-Ahumada C; Oros-Ovalle C; Navarrete-Solis J; Moncada B
    Am J Dermatopathol; 2011 May; 33(3):291-5. PubMed ID: 21317614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melasma: Updates and perspectives.
    Kwon SH; Na JI; Choi JY; Park KC
    Exp Dermatol; 2019 Jun; 28(6):704-708. PubMed ID: 30422338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
    Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
    Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melasma and aspects of pigmentary disorders in Asians.
    Kang HY
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S144-7. PubMed ID: 23522629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melasma: clinical diagnosis and management options.
    Rodrigues M; Pandya AG
    Australas J Dermatol; 2015 Aug; 56(3):151-63. PubMed ID: 25754098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis.
    Jang YH; Lee JY; Kang HY; Lee ES; Kim YC
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1312-6. PubMed ID: 20337826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
    Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
    Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melasma.
    Lee BW; Schwartz RA; Janniger CK
    G Ital Dermatol Venereol; 2017 Feb; 152(1):36-45. PubMed ID: 27589484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of dermal vascularity in melasma and solar lentigo.
    Hara Y; Shibata T
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12953. PubMed ID: 38353352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cadherin 11 Involved in Basement Membrane Damage and Dermal Changes in Melasma.
    Kim NH; Choi SH; Lee TR; Lee CH; Lee AY
    Acta Derm Venereol; 2016 Jun; 96(5):635-40. PubMed ID: 26671310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory Study of Epidermis, Basement Membrane Zone, Upper Dermis Alterations and Wnt Pathway Activation in Melasma Compared to Adjacent and Retroauricular Skin.
    Espósito ACC; Brianezi G; de Souza NP; Miot LDB; Miot HA
    Ann Dermatol; 2020 Apr; 32(2):101-108. PubMed ID: 33911720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melasma: histopathological characteristics in 56 Korean patients.
    Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
    Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of melasma and the use of intense pulsed light: a review.
    Zaleski L; Fabi S; Goldman MP
    J Drugs Dermatol; 2012 Nov; 11(11):1316-20. PubMed ID: 23135081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.
    Rusciani A; Motta A; Rusciani L; Alfano C
    J Drugs Dermatol; 2005; 4(6):770-4. PubMed ID: 16302566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of melasma and implications for treatment.
    Artzi O; Horovitz T; Bar-Ilan E; Shehadeh W; Koren A; Zusmanovitch L; Mehrabi JN; Salameh F; Isman Nelkenbaum G; Zur E; Sprecher E; Mashiah J
    J Cosmet Dermatol; 2021 Nov; 20(11):3432-3445. PubMed ID: 34411403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melasma. Etiologic and therapeutic considerations.
    Grimes PE
    Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutical approaches in melasma.
    Prignano F; Ortonne JP; Buggiani G; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):337-42, viii. PubMed ID: 17662899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated treatment protocols for melasma and acquired dermal melanocytosis.
    Yoshimura K; Sato K; Aiba-Kojima E; Matsumoto D; Machino C; Nagase T; Gonda K; Koshima I
    Dermatol Surg; 2006 Mar; 32(3):365-71. PubMed ID: 16640680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Melasma Treatments.
    Jo JY; Chae SJ; Ryu HJ
    Ann Dermatol; 2024 Jun; 36(3):125-134. PubMed ID: 38816973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.